跳到正文
AACR 官方会议报道· AACR·· 2026-04-19评分60

Clinical Trial Results: Long-term Updates on Approved Immunotherapies

Clinical Trial Results: Long-term Updates on Approved Immunotherapies

atezolizumab

导读

A record 265 clinical trial abstracts fed five minisymposia. The 'Updates in Anticancer Immunotherapies' session covered atezolizumab in alveolar soft part sarcoma: 54 patients enrolled as of June 2025, with responses lasting 10 to 69 months.

会议摘要

来源:AACR 官方会议报道 · aacr.org

CBACBA Frontier Insights (CFI)美国华人生物医药科技协会(CBA)www.cba-usa.org